Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms... Show more
ICLR is expected to report earnings to rise 5.08% to $2.69 per share on October 28
Q3'26
Est.
$2.69
Q2'26
Beat
by $0.01
Q1'26
Missed
by $0.48
Q4'25
Missed
by $0.11
Q3'25
Beat
by $0.01
The last earnings report on July 29 showed earnings per share of $2.56, beating the estimate of $2.55. With 143.77K shares outstanding, the current market capitalization sits at 12.59B.